A composition and method of using the composition for treating a patient inneed thereof, thecomposition comprising an oral formulation for enhanced bioavailability oftherapeutic agents such as thetaxane chemotherapeutic agents. The composition comprises the therapeuticagent and an absorptionenhancing agent either co-administered with the agent or administeredseparately, the therapeutic agentin a polymer matrix resulting in a microbead and including an edible oilresulting in an emulsion. Theabsorption enhancing agent is a cyclosporin in one embodiment. The absorptionenhancing agent is a Pglycoprotein inhibitor in another embodiment.
